{"@id":"https://bioecon.ru/technology/mucosal-vaccines-from-a-microbiota-platform/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/mucosal-vaccines-from-a-microbiota-platform/","json":"https://cn.bioecon.ru/api/v1/technology/mucosal-vaccines-from-a-microbiota-platform/index.json"},"id":"mucosal-vaccines-from-a-microbiota-platform","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/ridgeway-biologicals/","https://bioecon.ru/companies/rubinum/","https://bioecon.ru/companies/vaxxinova-norway/","https://bioecon.ru/companies/hipra/","https://bioecon.ru/companies/esco-aster/"]},"maturity":7,"name":"基于共生微生物组平台的黏膜免疫疫苗（ApyraVax）","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"共生菌外膜囊泡（OMV）低毒化工程重塑"},{"n":2,"title":"自转运蛋白嵌合展示外源病原体抗原"},{"n":3,"title":"生物黏附型干粉鼻腔喷雾剂型优化"},{"n":4,"title":"呼吸道黏膜分泌型sIgA灭菌性保护确证"}],"summary":"利用人源天然共生菌群外膜囊泡（OMV）及表面菌毛等非致病纳米结构开发的无针黏膜疫苗系统（ApyraVax），直接在鼻咽及呼吸道黏膜原位高保真展示病毒/细菌核心抗原，诱导极高亲和力分泌型IgA（sIgA）屏障以在感染入口阻断病原体。","url":"/technology/mucosal-vaccines-from-a-microbiota-platform/","verified":"2026-11-22"}